The effect of combined inhaler aromatherapy on nausea and vomiting of pregnancy
- Conditions
- ausea and vomiting of pregnancy.Hyperemesis gravidarum, mild or unspecified, starting before the end of the 22nd week of gestation
- Registration Number
- IRCT2014062914324N2
- Lead Sponsor
- Vice chancellor for research, Birjand University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 90
Pregnant women who are 16 to 40 years old, with 6 to16 weeks gestation; With literacy; With Singleton pregnancy; With mild to moderate nausea with or without vomiting (based on 3-12 PUQE-24 scores); Without any antiemetic or emetic drug use in the past 24 hours; Without tobacco use; Without psychological problems and unpleasant event during last 6 months; Pregnancy without signs of molar pregnancy and threatened abortion and pyelonephritis, thyroid dysfunction and digestive diseases and any other dis¬ease with nausea and vomiting as a symptom (vomiting according to pregnant women and physician examination); With phone number; Without olfactory disorder (according to patient). Exclusion criteria: Allergy or drug intolerance during intervention; Unwillingness to continue the study; using other drugs during the study.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of fatigue. Timepoint: Before and after intervention. Method of measurement: FSS questionnaire.;Severity of nausea and vomiting of pregnancy. Timepoint: Before and during intervention. Method of measurement: PUQE-24 questionnaire.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: After intervention. Method of measurement: Final questionnaire.;Satisfaction. Timepoint: After intervention. Method of measurement: Final questionnaire.